CELONTIN

This brand name is authorized in United States.

Active ingredients

The drug CELONTIN contains one active pharmaceutical ingredient (API):

`1`	Mesuximide UNII `0G76K8X6C0` - METHSUXIMIDE
	Mesuximide is a succinimide with anticonvulsant properties. Although the exact mechanism of action of methsuximide is unclear, it is thought to increase the seizure threshold and suppress the paroxysmal three-cycle-per-second spike-and-wave pattern seen with absence (petit mal) seizures.
	Read more about Mesuximide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CELONTIN Capsule	MPI, US: SPL/Old	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	0071-0525

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.